Caution: JavaScript execution is disabled in your browser or for this website. You may not be able to answer all questions in this survey. Please, verify your browser parameters.

GLP-1 medications & endometriosis — anonymous patient survey

An anonymous international survey of people with endometriosis/adenomyosis who have used a GLP-1 medication.

GLP-1 medications & endometriosis — an anonymous patient survey.

If you have endometriosis and/or adenomyosis and have taken a GLP-1 medication (e.g. Ozempic, Wegovy, Mounjaro, Zepbound, Saxenda, Rybelsus, Trulicity, or a compounded version), we would like to hear about your experience — whether your symptoms got better, stayed the same, or got worse. We want to hear from everyone.

This survey is anonymous: we do not ask for your name, email, or any contact details, and we do not log your IP address. It takes about 8–12 minutes.

This is research, not medical advice. GLP-1 medications are not approved to treat endometriosis. Nothing here is a recommendation to start, stop, or change any medication — discuss that only with your own clinician.

We combine everyone's answers and report only group statistics. Individual responses are never published. Once you submit, your response is anonymous and cannot be withdrawn because we cannot tell which one is yours. Lawful basis (GDPR): your explicit consent; health data is processed only in anonymised, aggregated form.

This survey is anonymous.

The record of your survey responses does not contain any identifying information about you, unless a specific survey question explicitly asked for it.

If you used an identifying access code to access this survey, please rest assured that this code will not be stored together with your responses. It is managed in a separate database and will only be updated to indicate whether you did (or did not) complete this survey. There is no way of matching identification access codes with survey responses.

Exit and clear survey